Hanyun Ren
Overview
Explore the profile of Hanyun Ren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Guo M, Nong L, Wang M, Zhang Y, Wang L, Sun Y, et al.
Ann Hematol
. 2023 Sep;
103(1):153-162.
PMID: 37749319
The purpose is to ascertain the clinical impact of Castleman disease (CD) by reassessment of the real-world data from Peking University First Hospital (PKUFH). The results will contribute to the...
12.
Wang Q, Liang Z, Ren H, Dong Y, Yin Y, Wang Q, et al.
Ann Hematol
. 2023 Sep;
102(11):3061-3074.
PMID: 37667046
Acute myeloid leukemia (AML) is a malignant lymphohematopoietic tumor that ranks among the most frequent indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT). This article aims to provide a comprehensive...
13.
Zhou H, Zhou J, Wu D, Ma L, Du X, Niu T, et al.
Res Pract Thromb Haemost
. 2023 Aug;
7(5):100192.
PMID: 37601010
Background: Multiple trials have confirmed that romiplostim could increase platelet count in individuals with primary immune thrombocytopenia (ITP), but no related study has assessed Chinese patients. Objectives: To assess the...
14.
Wang B, Yin Y, Li Y, Liang Z, Liu W, Sun Y, et al.
Transplant Proc
. 2023 Jun;
55(7):1706-1714.
PMID: 37385841
Background: Diagnosis of acute graft-vs-host disease (aGVHD) based on clinical symptoms and biopsy of involved organ was not satisfactory; reliable plasma biomarkers or their panels would be of great value...
15.
Xie W, Wang Q, Zhou F, Wang S, Sun Y, Cen X, et al.
Int J Hematol
. 2023 May;
118(2):231-241.
PMID: 37247070
Light chain amyloidosis is a plasma cell dyscrasia characterized by deposition of misfolded amyloid fibrils in tissues, leading to multi-organ dysfunction. We retrospectively analyzed 335 patients (median age, 60 years)...
16.
Zhu J, Wang Q, Liu Y, Dong Y, Liang Z, Yin Y, et al.
Int Immunopharmacol
. 2023 May;
120:110299.
PMID: 37201405
Donor-specific anti-HLA antibody (DSA) is a significant obstacle to successful haploidentical hematopoietic stem cell transplantation (haplo-HSCT) and is associated with poor engraftment rates. DSA strongly positive patients with a mean...
17.
Xie W, Liang Z, Wang Q, Wang B, Yin Y, Li Y, et al.
Ann Hematol
. 2023 May;
102(8):2293-2295.
PMID: 37126116
No abstract available.
18.
Yuan J, Wang F, Ren H
Stem Cell Res Ther
. 2023 Mar;
14(1):44.
PMID: 36941630
A 24-year-old man with central nervous system (CNS) involvement of T-cell lineage acute lymphoblastic leukemia received sibling allogeneic stem cell transplantation (allo-SCT). He developed isolated CNS relapse early post-SCT, while...
19.
Wang B, Wang Q, Liang Z, Yin Y, Wang L, Wang Q, et al.
Ann Hematol
. 2023 Mar;
102(4):961-966.
PMID: 36864209
Patients with hematological malignancies who experience severe infections are at risk of developing dangerous complications due to excessive inflammatory cytokines. To improve the prognosis, it is crucial to identify better...
20.
Han X, Zhang M, Wang H, Zhang Q, Li W, Hao M, et al.
Chin J Cancer Res
. 2023 Jan;
34(6):601-611.
PMID: 36714342
Objective: This multi-center, open-label, randomized, parallel-controlled phase II study aimed to compare the pharmacokinetics (PK), pharmacodynamics (PD) and safety profile of ripertamab (SCT400), a recombinant anti-CD20 monoclonal antibody, to rituximab...